Ólafsdóttir AF, Bolinder J, Heise T, et al. - In the present study, the researchers sought to identify responders to continuous glucose monitoring (CGM) in relation to decreases in HbA1c and percentage of time spent in hypoglycaemia following initiation of CGM for people with type 1 diabetes treated with multiple daily insulin injections. Data were analyzed from 142 candidates in the GOLD randomized clinical trial. Lower HbA1c reduction was correlated with greater reduction of hypoglycaemia. As measured by a hypoglycaemic confidence questionnaire, the variables associated with a greater reduction in time in hypoglycaemia were female sex, greater time with glucose levels below 3.0 mmol/L, higher CV, and greater hypoglycaemia confidence. CGM helps the majority of individuals with type 1 diabetes managed by multiple daily insulin injections; some experienced decreased HbA1c while others shortened the time spent on hypoglycaemia. Healthcare practitioners and decision-makers need to weigh these variables for recommendations on reimbursement and diabetes.